Page last updated: 2024-10-27

fentanyl and Lipodystrophy

fentanyl has been researched along with Lipodystrophy in 1 studies

Fentanyl: A potent narcotic analgesic, abuse of which leads to habituation or addiction. It is primarily a mu-opioid agonist. Fentanyl is also used as an adjunct to general anesthetics, and as an anesthetic for induction and maintenance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1078)
fentanyl : A monocarboxylic acid amide resulting from the formal condensation of the aryl amino group of N-phenyl-1-(2-phenylethyl)piperidin-4-amine with propanoic acid.

Lipodystrophy: A collection of heterogenous conditions resulting from defective LIPID METABOLISM and characterized by ADIPOSE TISSUE atrophy. Often there is redistribution of body fat resulting in peripheral fat wasting and central adiposity. They include generalized, localized, congenital, and acquired lipodystrophy.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amano, N1
Katagai, H1
Shirasaki, S1
Matsuki, A1
Oyama, T1

Other Studies

1 other study available for fentanyl and Lipodystrophy

ArticleYear
[Anesthesia for a patient with Nasu-Hakola's disease].
    Masui. The Japanese journal of anesthesiology, 1984, Volume: 33, Issue:12

    Topics: Adult; Droperidol; Fentanyl; Humans; Lipodystrophy; Male; Neuroleptanalgesia; Nitrous Oxide

1984